Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
The market capitalization of stablecoins has increased by $4.85 billion within one month

The market capitalization of stablecoins has increased by $4.85 billion within one month

2024/01/31 14:50

According to Bitcoin.com, data shows that the total market value of stablecoins has significantly increased in the past month, from $131.71 billion to $136.56 billion, an increase of $4.85 billion.

The top two stablecoins, Tether and USD Coin, have seen a significant increase in supply, with growth rates of 4.8% and 7.2% respectively.

Maker's stablecoin DAI has slightly declined by 0.8%.

The supply of TUSD has sharply decreased, decreasing by 30.6% within 30 days.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The "copper rush" cools off? LME sees the largest delivery in nearly four weeks, copper price retreats to $14,000

Copper prices have stabilized around $14,000 per ton after previously falling, as exchange-tracked warehouses have experienced a new round of inventory deliveries, indicating that the supply shortage has somewhat eased.

智通财经2026/09/15 04:01
The "copper rush" cools off? LME sees the largest delivery in nearly four weeks, copper price retreats to $14,000

Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage

Eli Lilly stated on Monday that its oral weight-loss drug, Foundayo, has captured over 30% of the market share among new patients in the US oral obesity treatment market, narrowing the early lead achieved by Danish competitor Novo Nordisk with its Wegovy oral tablets.

智通财经2026/09/15 03:21
Competition in US oral weight-loss drugs intensifies! Eli Lilly (LLY.US) Foundayo captures 30% of new patients, narrowing Novo Nordisk's (NVO.US) first-mover advantage